2022, Número 2
Left Main Coronary Artery Disease in the new 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A word of criticism
Idioma: Ingles.
Referencias bibliográficas: 6
Paginas: 21-22
Archivo PDF: 129.98 Kb.
FRAGMENTO
Sin resumen.REFERENCIAS (EN ESTE ARTÍCULO)
Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM,Bittl JA, Cohen MG, DiMaio JM, Don CW, Fremes SE, Gaudino MF, GoldbergerZD, Grant MC, Jaswal JB, Kurlansky PA, Mehran R, Metkus TS Jr, Nnacheta LC,Rao SV, Sellke FW, Sharma G, Yong CM, Zwischenberger BA. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the AmericanCollege of Cardiology/American Heart Association Joint Committee on ClinicalPractice Guidelines. Circulation. (2021):CIR0000000000001038. doi: 10.1161/CIR.0000000000001038.
Bittl JA, He Y, Jacobs AK, Yancy CW, Normand SL; American College of CardiologyFoundation/American Heart Association Task Force on Practice Guidelines.Bayesian methods affirm the use of percutaneous coronary intervention to improvesurvival in patients with unprotected left main coronary artery disease. Circulation.2013;127(22):2177-85. doi: 10.1161/CIRCULATIONAHA.112.000646.